ECULIZUMAB FOR RESCUE OF THROMBOTIC MICROANGIOPATHY IN MALIGNANT HYPERTENSION ASSOCIATED WITH MCTD

被引：0
|
作者：
Date, Ryosuke [1 ]
Kajiwara, Kengo [2 ]
Johno, Takamitsu [2 ]
Ko, Takehiro [3 ]
Nakamura, Tomofumi [2 ]
Tomita, Masao [2 ]
Mizumoto, Teruhiko [1 ]
Kakizoe, Yutaka [1 ]
Izumi, Yuichiro [1 ]
Kuwabara, Takashige [1 ]
Adachi, Masataka [1 ]
Mukoyama, Masashi [1 ]
机构：
[1] Kumamoto Univ, Grad Sch Med Sci, Dept Nephrol, Kumamoto, Japan
[2] Natl Hosp Org Kumamoto Med Ctr, Kumamoto, Japan
[3] Kumamoto Kenhoku Hosp, Kumamoto, Japan
来源：
JOURNAL OF HYPERTENSION | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
PS-BPR02-2
引用
收藏
页码：E349 / E349
页数：1
相关论文
共 50 条
  • [21] Malignant hypertension as a cause of thrombotic microangiopathy in a pediatric patient
    Ozcakar, Z. B.
    Yalcinkaya, F.
    Ensari, A.
    Kendirli, T.
    Ekim, M.
    Fitoz, S.
    PEDIATRIC NEPHROLOGY, 2008, 23 (09) : 1662 - 1662
  • [22] The endothelium as the common denominator in malignant hypertension and thrombotic microangiopathy
    Mathew, Roy O.
    Nayer, Ali
    Asif, Arif
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2016, 10 (04) : 352 - 359
  • [23] RARE CASE OF MALIGNANT HYPERTENSION CAUSING THROMBOTIC MICROANGIOPATHY
    Vashistha, Kirtivardhan
    Elhamdani, Adee
    Yasir, Muhammad
    Lygouris, Georgios
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 2919 - 2919
  • [24] The use of eculizumab in Capnocytophaga canimorsus associated thrombotic microangiopathy: a case report
    Bjorkto, Magnus Holter
    Barratt-Due, Andreas
    Nordoy, Ingvild
    Dorje, Christina
    Galteland, Eivind
    Lind, Andreas
    Hilli, Abdulkarim
    Aukrust, Pal
    Mjoen, Geir
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [25] Improved Outcomes of Transplant Associated Thrombotic Microangiopathy with Early Initiation of Eculizumab
    Sardar, Muhammad
    Katsanis, Emmanuel
    Maher, Keri Renee
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S130 - S130
  • [26] Bevacizumab-Associated Thrombotic Microangiopathy Treated with Eculizumab: A Case Report
    Padilha, Wallace Stwart Carvalho
    Cesar, Bruno Nogueira
    Pacheco, Samara Theodoro
    De Sousa, Alessandra Alves
    Ledesma, Felipe Lourenco
    Malheiros, Denise Maria Avancini Costa
    Teixeira, Marcela Crosara Alves
    AMERICAN JOURNAL OF CASE REPORTS, 2023, 24
  • [27] Use of Eculizumab in Thrombotic Microangiopathy Associated with Hematopoietic Stem Cell Transplantation
    Demircioglu, Sinan
    Dogan, Ali
    Demir, Cengiz
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2021, 31 (11): : 1359 - 1361
  • [28] The use of eculizumab in Capnocytophaga canimorsus associated thrombotic microangiopathy: a case report
    Magnus Holter Bjørkto
    Andreas Barratt-Due
    Ingvild Nordøy
    Christina Dörje
    Eivind Galteland
    Andreas Lind
    Abdulkarim Hilli
    Pål Aukrust
    Geir Mjøen
    BMC Infectious Diseases, 21
  • [29] UNDERSTANDING THE MECHANISMS OF ECULIZUMAB REFRACTORINESS IN PATIENTS WITH TRANSPLANT ASSOCIATED THROMBOTIC MICROANGIOPATHY
    Ibrahimova, Azada
    Luebbering, Nathan
    Duell, Alexandra
    Lake, Kelly E.
    Davies, Stella M.
    Jodele, Sonata
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S192 - S192
  • [30] "Eculizumab First" in the Management of Posttransplant Thrombotic Microangiopathy
    Maritati, Federica
    Corradetti, Valeria
    Bini, Claudia
    Provenzano, Michele
    Cuna, Vania
    Busutti, Marco
    Tondolo, Francesco
    Zappulo, Fulvia
    Vischini, Gisella
    Iacovella, Francesca
    Abenavoli, Chiara
    Borelli, Greta
    Demetri, Marcello
    Fabbrizio, Benedetta
    Radi, Giorgia
    Ravaioli, Matteo
    Mele, Caterina
    La Manna, Gaetano
    Comai, Giorgia
    KIDNEY INTERNATIONAL REPORTS, 2023, 9 (04): : 982 - 993
12345